What Changed in the GLP-1 Market in 2025–2026
Why does this timeline matter for a Noom Med vs Luma Health comparison? Because the 2023–2024 context — when access was the primary concern and price competition was limited — no longer applies. In 2026, compounded semaglutide is readily available from multiple legitimate platforms. The decision point has shifted from "can I get GLP-1?" to "which platform gives me the best value, transparency, and fit?" The 2026 comparison looks meaningfully different from what patients found in 2023 articles.
What Changed Specifically at Noom Med
Mandatory dual-subscription structure formalized
Noom Med's bundled model — medication subscription plus separate Noom app subscription — was formalized as the standard product. The app is not optional. This creates an effective monthly total of ~$181–$279/mo (medication ~$149–$209 + app ~$32–$70) that's higher than the medication-only rate Noom Med may have advertised historically.
Compounded GLP-1 pricing competition intensified
Noom Med's combined effective rate (~$181–$279/mo) was less distinguishable from alternatives when competition was sparse. In 2026, multiple platforms offer comparable or lower cash-pay rates — Luma Health $197/mo flat, Henry Meds ~$145/mo annual, Ro starting ~$145/mo — making Noom Med's app overhead more visible as a cost driver rather than a differentiator.
Pharmacy disclosure remains limited
Noom Med has not added prominent public disclosure of the specific compounding pharmacy(ies) preparing their GLP-1 medications. Patients cannot independently verify the pharmacy's state board license before enrolling. This gap has become more visible as platforms like Luma Health (VialsRX TX#35264) make pre-enrollment pharmacy verification a standard offering.
Clinical evidence base expanded (SURMOUNT-OSA, FLOW)
New Phase 3 data published in 2024 extends the evidence for both semaglutide (FLOW — kidney disease outcomes) and tirzepatide (SURMOUNT-OSA — sleep apnea reduction). The underlying clinical case for GLP-1 is stronger now than in 2023 comparisons. This benefits all GLP-1 platforms equally.
Dual cancellation requirement confirmed
Exiting Noom Med requires canceling two separate subscriptions: the medication access and the Noom app. These are different billing items billed on potentially different dates. Canceling one does not cancel the other. This creates exit friction that wasn't as visible in early coverage when fewer patients had gone through cancellation.
Noom Med True Monthly Cost — 2026
Noom Med — Effective Monthly Total (Verified June 2026)
Full 2026 Comparison: Noom Med vs Luma Health
| Factor | Noom Med | Luma Health |
|---|---|---|
| Sema monthly (effective) | ~$181–$279/mo combined | $197/mo flat (single subscription) |
| Annual sema total | ~$2,172–$3,348/yr | $2,364/yr flat |
| App subscription required | Yes — $32–$70/mo additional | None |
| Behavioral coaching included | ✓ Noom psychology methodology | Not included |
| Pharmacy named publicly | Not prominently | ✓ VialsRX TX#35264 — verify before payment |
| Pricing model | Dose-tier + app (2 bills) | Flat — same price all doses (1 bill) |
| Subscriptions to cancel at exit | 2 — medication AND Noom app separately | 1 — single subscription |
| Tirzepatide | Available (verify current) | $297/mo flat |
| HRT / adjunct services | Not typically offered | ✓ NAD+ / HRT $100/mo |
| Insurance for compounded | No — cash-pay only | No — cash-pay only |
| 50-state availability | ✓ All 50 states | ✓ All 50 states |
| Clinical entity | Noom Medical Group | Wasef Health, PC |
Who Should Choose Noom Med vs Luma Health in 2026
Choose Noom Med If...
- ○ The Noom behavioral psychology methodology resonates with you — food psychology, calorie density, habit tracking — and you will use the app daily
- ○ You've used Noom before and know the platform fits your learning style
- ○ You want behavioral coaching bundled with medication in a single provider relationship
- ○ You're comfortable with the $181–$279/mo effective combined rate
- ○ You understand and accept the dual-subscription exit requirement
★ Choose Luma Health If...
- ✓ You want compounded semaglutide without a mandatory app subscription adding $32–$70/mo
- ✓ You want pharmacy named publicly before enrolling (VialsRX TX#35264)
- ✓ You want one flat rate ($197/mo sema) that never changes regardless of dose
- ✓ You want a single subscription with simple cancel-anytime exit
- ✓ You want HRT or NAD+ adjunct services alongside GLP-1 through one provider
Frequently Asked Questions
What are the most recent changes to Noom Med's GLP-1 program?
As of June 2026, Noom Med's core structure — compounded GLP-1 medication bundled with a mandatory Noom app subscription — has remained the defining feature of their program. The mandatory app makes Noom Med's effective monthly total approximately $181–$279/month (medication ~$149–$209 plus app ~$32–$70) rather than the medication-only rate. The most significant market change affecting Noom Med is competitive: more platforms now offer comparable or lower cash-pay rates, making Noom Med's app overhead more visible as a cost driver. Verify current Noom Med pricing directly at noom.com/med before enrolling — rates change periodically.
Is Noom Med or Luma Health cheaper in 2026?
Luma Health is less expensive for most patients at most dose levels. Noom Med's effective combined rate (~$181–$279/month) exceeds Luma Health's $197/month flat for patients whose medication dose falls at the higher end of Noom's range, and is comparable at the lower end only if the Noom app adds genuine behavioral value. Annually, Luma Health's $2,364/year flat is approximately $396+ less than Noom Med at the midpoint combined rate (~$2,760/year). Patients who won't consistently use Noom's behavioral app receive less value per dollar at Noom Med than at Luma Health.
Does Noom Med still require the Noom app subscription?
Yes. As of June 2026, the Noom app subscription remains mandatory as part of Noom Med's GLP-1 program structure. The app costs approximately $32–$70/month depending on your plan tier. It is not an optional add-on — it is a required component of the Noom Med program. Patients primarily seeking medication access without behavioral app infrastructure are paying for a service they won't use. Verify the current app subscription requirement and cost directly at noom.com/med before enrolling.
How do I cancel Noom Med in 2026?
Canceling Noom Med requires canceling two separate subscriptions: (1) the GLP-1 medication access through the Noom Med clinical portal, and (2) the Noom app subscription through noom.com account settings. Canceling one does not cancel the other — these are separate billing relationships. Get written email confirmation with specific effective dates for both cancellations. Monitor both billing items through the next billing cycle after cancellation confirmation. For the complete step-by-step cancellation process, see our Noom Med exit checklist.
Has the semaglutide shortage affected Noom Med or Luma Health in 2026?
The FDA declared semaglutide no longer in shortage in early 2025. Both Noom Med and Luma Health operate under 503A patient-specific compounding frameworks that remain valid after the shortage declaration under applicable FDA guidance for compounding pharmacies. VialsRX (Luma Health's pharmacy, TX#35264) has maintained consistent supply. The shortage-era context — where platforms received more benefit of the doubt due to limited alternatives — no longer applies. Patients evaluating platforms in 2026 can compare on value, transparency, and fit rather than access alone.
Is Noom's behavioral program worth the extra cost over medication-only GLP-1?
For patients who actively engage with Noom's behavioral methodology — food psychology, calorie density education, habit tracking, peer groups — the extra ~$32–$70/month in app cost has documented behavioral health value. Noom's approach to cognitive behavioral psychology around eating is a real differentiator from medication-only platforms. The key word is "actively." For patients who download the app but don't open it weekly, or who find the Noom methodology doesn't resonate with their learning style, the app cost is overhead without proportional benefit. Honest assessment: if you've tried Noom before and it worked for you behaviorally, the premium is justified. If you're skeptical about app-based coaching or have tried and disengaged, a medication-only platform at lower cost is the more efficient choice.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
- Rubino DM, et al. Effect of Continued Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414–1425. PubMed
- Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med. 2023;389:2221–2232. PubMed
- Perkovic V, et al. Effects of Semaglutide on Chronic Kidney Disease (FLOW). N Engl J Med. 2024;391:109–121. PubMed
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed
- FDA. Human Drug Compounding — Section 503A. FDA.gov
- Noom. Noom Med Program. noom.com/med
- Texas State Board of Pharmacy. License Verification. pharmacy.texas.gov